Phase 2 Graft-Versus-Host-Disease (GVHD) Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors
Graft-Versus-Host-Disease (GVHD)Bone Marrow Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine82 enrolled1 locationNCT07570745
Recruiting
Phase 2
Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention
Graft-Versus-Host-Disease (GVHD)allogeneic stem cell transplantationHematologic Malignancies
Milton S. Hershey Medical Center41 enrolled1 locationNCT06926595
Recruiting
Phase 2
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Graft-Versus-Host-Disease (GVHD)Hematological Malignancies
University of Nebraska126 enrolled1 locationNCT06799195
Recruiting
Phase 2
Dapagliflozin in Allo-HCT for aGVHD
Graft-Versus-Host-Disease (GVHD)
The First Affiliated Hospital of Soochow University72 enrolled1 locationNCT06626737